TEL:020-31701980      FAX:020-31701979     E-mail:sales@mx008.com
China Mingxuan
Service Hotline:020-3171980
搜索

News
MX trends
industry trends
fair information
 
Micro-channel
 
Information details You are here:Home >> News >> industry trends
 
In the 2017 edition of the drug catalog, the growth rate was 15.4%
 
Author:中国铭铉 企划部  Release Time:2017-5-25 9:10:17  Number Browse:493
 
Medical network - May 24, according to people club department website recently, people club department issued "about printing of < the national basic medical insurance, inductrial injury insurance and maternity insurance drug catalogue (2017 edition) > notice, formally announced the 2017 national basic medical insurance, inductrial injury insurance and maternity insurance drug catalogue. There were 2,535 medicines for western and Chinese medicine, up 339 from the 2009 edition, and the increase was about 15.4 percent. No adjustment was made in the Chinese medicine section. 
 
The catalogue adjustment was made by nearly 4, 000 clinicians, pharmacists and health care professionals from all the provinces and cities across the country. 
 
The catalogue of medicines for 2017 will be composed of four parts: general, western medicine, Chinese medicine and Chinese medicine. Notice is on drug catalogue format, name, dosage form, limited to pay limits the content such as explanation and illustration, western medicine section includes chemical medicines and biological products, proprietary Chinese medicine section includes proprietary Chinese medicine and ethnic medicine, Chinese medicine yinpian part adopts slices method specifies the fund does not grant to pay. There were 2,535 medicines for western and Chinese medicine, up 339 from the 2009 edition, and the increase was about 15.4 percent. Of them, 1,297 western medicine and 1,238 Chinese medicine (88). The Chinese medicine section has not been adjusted, and it is still used in the 2009 edition of the pharmaceutical catalogue. 
 
In addition, the 45 quasi-negotiation drugs are identified by expert review, all of which are the patents and exclusive medicines that are of high clinical value but relatively expensive. The next step will be to make sure that the business is in the process of negotiating a list of the drugs to negotiate with the relevant procedures. 
 
2017 drug directory is completely determined by expert evaluation, reflects the "fill a vacancy, selection, support innovation, encourage competition policy thinking, for medicine, children's medicine, innovative medicine of inductrial injury insurance, major disease treatment medicine and national medicine to consider and support. 
 
Experts agree that the 2017 version of a significant increase in the basic medical insurance drug catalogue drug coverage, improve the medical security level, is the party and the government to improve the treatment of medical treatment guarantee of the important measures, is conducive to easing the burden on the ginseng protect personnel to catalog and drug expenses, is beneficial to support clinical medical technology advancement, also is helpful to promote the development of China's pharmaceutical industry innovation. Next, the ministry of human resources will direct the implementation of the catalogue of medicines in the provinces (regions and cities), and benefit the masses of the people as early as possible. 

 
Previous article:The price of all eligible children's indications for the fitness of children is being negotiated or reduced in price
Next article:The state office has promoted the practice of social medicine: accelerating the development of specialized services
 
Log in  Website Map All right reserved by China Mingxuan, Guangzhou ICP #16026227
    

粤公网安备 44011202000029号